pharma

The Need for Rapid Reskilling in an Ever-changing Landscape

ACTO Acquires Scrimmage, Disrupting Life Sciences Learning and Engagement Market

Episode 6: Pharma Sales – Today versus Tomorrow

Digital Transformation Ideals of Change – Prescription for Pharma and Medical Device Trainers for Rapid Reskilling

CEO Parth Khanna’s Interview with Dr. Bertalan Mesko from The Medical Futurist, on Life Sciences Education

ACTO launches LAICA, the first AI-powered conversational assistant for Life Sciences learning

ACTO Bolsters Executive Management Team to Meet Significant US Commercial Growth

ACTO Acquires Scrimmage

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

ACTO Earns Gold at Brandon Hall Technology Awards 2021

Four Fundamentals for Telling Your Clinical Evidence Story

ACTO Kicks Off 2021 with Chart-Topping Growth

Fighting the Forgetting Curve: The Life Sciences Trainer’s Guide to Microlearning

Rapid Reskilling in an Ever-Changing Landscape

How Life Sciences Companies Can Level Up Healthcare Education in Post-COVID Era

New Era; New Launch Excellence Blueprint for 2021-2022

Life Sciences’ Transformative Journey to Consolidation in 2021 and What to Expect in 2022

Episode 2: How to Accelerate Drug and Device Launch in the Post-COVID World

Episode 4: Agile Change Management for Life Sciences Leaders

What Does ACTO’s Acquisition of CoHealth Mean for Patient Education?

New Era; New Launch Excellence Blueprint for 2021-2022

New Era; New Launch Excellence Blueprint for 2021-2022

The Triple A Initiative: ACTO, Axiom, and AstraZeneca

The Triple A Initiative: ACTO, Axiom, and AstraZeneca